The Pharmacokinetics of Acetanilide and of Diphenylhydantoin Sodium

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 1974 Oct 4

PMID 4439870

Citations 5

Authors

J L Cunningham

M F Bullen

D A Evans

Affiliations

Soon will be listed here.

Citing Articles

Disposition of antipyrine and phenytoin correlated with age and liver volume in man.

Bach B, Hansen J, Kampmann J, Rasmussen S, SKOVSTED L Clin Pharmacokinet. 1981; 6(5):389-96.

PMID: 7333060 DOI: 10.2165/00003088-198106050-00005.

Acetanilide and paracetamol pharmacokinetics before and during phenytoin administration: genetic control of induction?.

Cunningham J, Evans D Br J Clin Pharmacol. 1981; 11(6):591-5.

PMID: 7272175 PMC: 1402207. DOI: 10.1111/j.1365-2125.1981.tb01175.x.

The acute effects of ethanol on acetanilide disposition in normal subjects, and in patients with liver disease.

McKay J, Rawlings M, Cobden I, James O Br J Clin Pharmacol. 1982; 14(4):501-4.

PMID: 7138735 PMC: 1427598. DOI: 10.1111/j.1365-2125.1982.tb02019.x.

Hepatic drug acetylation and oxidation: effects of aging in man.

Farah F, Taylor W, Rawlins M, James O Br Med J. 1977; 2(6080):155-6.

PMID: 871823 PMC: 1631052. DOI: 10.1136/bmj.2.6080.155.

Playfer J, Baty J, Lamb J, Powell C, PRICE-EVANS D Br J Clin Pharmacol. 1978; 6(6):529-33.

PMID: 728323 PMC: 1429687. DOI: 10.1111/j.1365-2125.1978.tb00878.x.

References

Davies D, Thorgeirsson S . Mechanism of hepatic drug oxidation and its relationship to individual differences in rates of oxidation in man. Ann N Y Acad Sci. 1971; 179:411-20. DOI: 10.1111/j.1749-6632.1971.tb46918.x. View

Butler T . The metabolic conversion of 5, 5-diphenyl hydantoin to 5-(p-hydroxyphenyl)-5-phenyl hydantoin. J Pharmacol Exp Ther. 1957; 119(1):1-11. View

Solomon H, Schrogie J . The effect of phenyramidol on the metabolism of diphenylhydantoin. Clin Pharmacol Ther. 1967; 8(4):554-6. DOI: 10.1002/cpt196784554. View

Renson J, Weissbach H, UDENFRIEND S . Hydroxylation of tryptophan by phenylalanine hydroxylase. J Biol Chem. 1962; 237:2261-4. View

Tyrer J, Eadie M, Sutherland J, Hooper W . Outbreak of anticonvulsant intoxication in an Australian city. Br Med J. 1970; 4(5730):271-3. PMC: 1819816. DOI: 10.1136/bmj.4.5730.271. View

Lund L . Clinical significance of generic inequivalence of three different pharmaceutical preparations of phenytoin. Eur J Clin Pharmacol. 1974; 7(2):119-24. DOI: 10.1007/BF00561325. View

Brodie B, Axelrod J . The estimation of acetanilide and its metabolic products, aniline, N-acetyl p-aminophenol and p-amino-phenol, free and total conjugated, in biological fluids and tissues. J Pharmacol Exp Ther. 1948; 94(1):22-8. View

LOESER Jr E . Studies on the metabolism of diphenylhydantoin (Dilantin). Neurology. 1961; 11:424-9. DOI: 10.1212/wnl.11.5.424. View

PARE C, Sandler M, STACEY R . Decreased 5-hydroxytryptophan decarboxylase activity in phenylketonuria. Lancet. 1958; 2(7056):1099-101. DOI: 10.1016/s0140-6736(58)92471-1. View

10.

Lund L, Lunde P, Rane A, Borga O, Sjoqvist F . Plasma protein binding, plasma concentrations, and effects of diphenylhydantoin in man. Ann N Y Acad Sci. 1971; 179:723-8. DOI: 10.1111/j.1749-6632.1971.tb46947.x. View

11.

Orrenius S . Molecular aspects of drug metabolism. Acta Pharmacol Toxicol (Copenh). 1971; 29 Suppl 3:191-202. DOI: 10.1111/j.1600-0773.1971.tb03299.x. View

12.

PARE C, Sandler M, STACEY R . The relationship between decreased 5-hydroxyindole metabolism and mental defect in phenylketonuria. Arch Dis Child. 1959; 34:422-5. PMC: 2012407. DOI: 10.1136/adc.34.177.422. View

13.

Brodie B, Axelrod J . The fate of acetanilide in man. J Pharmacol Exp Ther. 1948; 94(1):29-38. View

14.

Borga O, Garle M, Gutova M . Identification of 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin as a metabolite of 5,5-diphenylhydantoin (phenytoin) in rats and man. Pharmacology. 1972; 7(3):129-37. DOI: 10.1159/000136282. View

15.

Conard G, Haavik C, FINGER K . Binding of 5,5-diphenylhydantoin and its major metabolite to human and rat plasma proteins. J Pharm Sci. 1971; 60(11):1642-6. DOI: 10.1002/jps.2600601110. View

16.

Mitoma C . Studies on partially purified phenylalanine hydroxylase. Arch Biochem Biophys. 1956; 60(2):476-84. DOI: 10.1016/0003-9861(56)90453-2. View

17.

Hammer W, Martens S, Sjoqvist F . A comparative study of the metabolism of desmethylimipramine, nortriptyline, and oxyphenylbutazone in man. Clin Pharmacol Ther. 1969; 10(1):44-9. DOI: 10.1002/cpt196910144. View

18.

Evans D, MANLEY K, MCKUSICK V . Genetic control of isoniazid metabolism in man. Br Med J. 1960; 2(5197):485-91. PMC: 2097108. DOI: 10.1136/bmj.2.5197.485. View

19.

KUTT H, McDowell F . Management of epilepsy with diphenylhydantoin sodium. Dosage regulation for problem patients. JAMA. 1968; 203(11):969-72. View

20.

Lund L, Alvan G, Berlin A, Alexanderson B . Pharmacokinetics of single and multiple doses of phenytoin in man. Eur J Clin Pharmacol. 1974; 7(2):81-6. DOI: 10.1007/BF00561319. View